Background-Dilated cardiomyopathy is often associated with mitral regurgita
tion (MR), or so-called functional MR, the mechanism of which continues to
be debated. We studied the valvular and ventricular 3D geometric perturbati
ons associated with MR in an ovine model of tachycardia-induced cardiomyopa
thy (TIC).
Methods and Results-Nine sheep underwent myocardial marker implantation in
the left ventricle (LV), mitral annulus. and mitral leaflets. After 5 to 8
days, the animals were studied with biplane videofluoroscopy (baseline), an
d mitral competence was assessed by transesophageal echocardiography. Rapid
ventricular pacing (180 to 230 bpm) was subsequently initiated for 15 +/-6
days until the development of TIC and MR, whereupon biplane videofluorosco
py and transesophageal echocardiography studies were repeated. LV volume wa
s calculated from the epicardial marker array. Valve closure time was defin
ed as the time after end diastole when the distance between leaflet edge ma
rkers reached its minimal plateau. TIC resulted in increased LV end-diastol
ic volume (P=0.001) and LV end-systolic volume (P=0.0001) and greater LV sp
hericity (P=0.02). MR increased significantly (grade 0.2 +/-0.3 versus 2.2
+/-0.9, P=0.0001), as did mitral annulus area (817 +/- 146 versus 1100 +/-
161 mm(2), P=0.0001) and mitral annulus septal-lateral diameter (28.2 +/-3.
5 versus 35.1 +/-2.6 nim, P=0.0001). Time of valve closure (70 +/- 18 versu
s 87 +/- 14 ms, P=0.23) and angular displacement of both the anterior (29 /-5 degrees versus 27 +/-3 degrees, P=0.3) and posterior (55 +/-5 degrees v
ersus 44 +/- 11 degrees, P=0.13) leaflet edges relative to the mitral annul
us after valve closure did not change, but leaflet edge separation after cl
osure increased (5.2 +/-0.9 versus 6.8 +/-1.2 mm, P=0.019).
Conclusions-MR in TIC resulted from decreased leaflet coaptation secondary
to annular dilatation in the septal-lateral direction. These data support t
he use of annular reduction procedures, such as rigid, complete ring annulo
plasty, to address functional MR in patients with dilated cardiomyopathy.